Mille-Loera JE

Language: Spanish
References: 12
Page: 78-83
PDF size: 521.97 Kb.

Text Extraction

No abstract

REFERENCES

1. Gantt CL. Red cells for cancer patients. Lancet 1981;2:363.

2. Vamvakas EC, Blajchman MA. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood 2001;97:1180-1195.

3. Leal-Noval SR, Jara-López I, García-Garmendia JL. Influence of red blood cell concentrates (Red blood cell) storage time on postsurgical morbidity in cardiac surgery patients. Anesthesiology 2003;98:815-822.

4. Frenzel T, Van Aken H, Westphal M. Our own blood is still the best thing to have in our veins. Curr Opin Anaesthesiol 2008;21:657-663.

5. Rawn J. The silent risk of blood transfusion. Curr Opin Anaesthesiol 2008;21:664-668.

6. Muñoz M, Gómez LA, Naveíra AE. Erythrocyte transfusion and postsurgical morbidity in cardiac surgery patients: Is it The storage time or the number of transfused concentrates what really matters? Anethesiology 2004;100:193-194.

7. Muñoz GM, García EJA, Gómez LA. Manejo racional de la transfusión sanguínea en el paciente con cáncer. En: Plancarte SR, Torres AL, Mille LJE, Guajardo RJ. Medicina Perioperatoria en el Paciente con Cáncer. El Manual Moderno. México, 2006;28:261-279.

8. Añón JM, García de Lorenzo A, Quintana M, González E, Bruscas MJ. Lesión pulmonar aguda por transfusión. Med Intensiva 2009;10:1-11.

9. Laurie J, Wyncoll D, Harrison C. New versus old blood – the debate continues. Critical Care 2010;14:130-131.

10. Glance LG, Dick W, Mukamel DB, Fleming FJ, Zollo RA, Wissler R, Salloum R, Meredith UW, Osler TM. Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology 2011;114:283-292.

11. Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: A systematic review of the literature. Crit Care Med 2008:36:2667-2674.

12. Sphan N. More on transfusion and adverse outcome. It’s time to change. Anesthesiology 2011;114:234-236.